London (BBC)—The first human trial in Europe of a coronavirus vaccine has begun in Oxford.Two volunteers were injected, the first of more than 800 people recruited for the study.Elisa Granato, one of the two who received the jab, told the BBC: "I'm a scientist, so I wanted to try to support the scientific process wherever I can."Half will receive the Covid-19 vaccine, and half a control vaccine which protects against meningitis but not coronavirus. The design of the trial means volunteers will not know which vaccine they are getting, though doctors will.The vaccine was developed in under three months by a team at Oxford University. The vaccine is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees that has been modified so it cannot grow in humans.The vaccine researchers are prioritising the recruitment of local healthcare workers into the trial as they are more likely than others to be exposed to the virus Source: BBC.com
FINANCED BY
This project was funded in part through a U.S. Embassy grant. The opinions, findings, and conclusions or recommendations expressed herein are those of the implementers/authors and do not necessarily reflect those of the U.S. Government.
PARTNERS
